ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "ResMed wins patent spat with NYU, Haemonetics closes $255M OpSens buy"
Episode Synopsis
Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, December 13, 2023.
Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.
Cognito Therapeutics reported non-invasive neuromod data for treating Alzheimers this week. Fast Five hosts Danielle Kirsh and Sean Whooley talk about how the company's technology works and some of the data points that stuck out in the report.
Shifamed's Laza Medical closed a $36M Series A funding round to support cardiac imaging technology. Hear what the technology is and what the company hopes to achieve with the imaging technology.
Vivasure has treated the first patients with its percutaneous vessel closure device. Learn more about how the device works and what makes it unique in today's episode.
Haemonetics has closed its previously announced acquisition of OpSens. Whooley explains what OpSens brings to Haemonetics and some of the financial details of the deal.
ResMed has won a patent spat with NYU. The Fast Five hosts discuss the details of the patent spat and the device behind the legal battle.
Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.
Cognito Therapeutics reported non-invasive neuromod data for treating Alzheimers this week. Fast Five hosts Danielle Kirsh and Sean Whooley talk about how the company's technology works and some of the data points that stuck out in the report.
Shifamed's Laza Medical closed a $36M Series A funding round to support cardiac imaging technology. Hear what the technology is and what the company hopes to achieve with the imaging technology.
Vivasure has treated the first patients with its percutaneous vessel closure device. Learn more about how the device works and what makes it unique in today's episode.
Haemonetics has closed its previously announced acquisition of OpSens. Whooley explains what OpSens brings to Haemonetics and some of the financial details of the deal.
ResMed has won a patent spat with NYU. The Fast Five hosts discuss the details of the patent spat and the device behind the legal battle.
More episodes of the podcast Fast Five Medtech News Podcast
Edwards reports new outcomes with TAVR; SafeGuard wins breakthrough nod for biodegradable stent
15/03/2024
Former Stimwave CEO convicted of healthcare fraud; GE HealthCare establishes charitable foundation
14/03/2024
iRhythm closes offering worth more than $660M; FDA accepts Onward BCI into advisory program
12/03/2024
Fast Five: FTC may look at Boston Scientific's Axonics buy, Roche unveils new AI-enabled CGM
08/03/2024
Fast Five: Haemonetics buys Attune Medical, Medtronic faces jury trial in spine implant suit
06/03/2024
In God we trust